Champions Biotechnology, Inc. (CSBR) and Concurrent Pharmaceuticals Establish Royalty Agreement for Novel Oncology Drug
1/12/2009 10:03:10 AM
More...
|
Concurrent Pharmaceuticals Changes Name To Vitae Pharmaceuticals And Secures $34 Million In Financing
10/19/2005 5:11:34 PM
More...
|
Concurrent Pharmaceuticals Acquires Rights To Allergan Inc. (AGN) Retinoid Portfolio To Accelerate Drug Development Programs -- Concurrent Progresses To Integrated Drug Discovery And Development Company With Preclinical Candidates In Four Major Therapeutic Areas
10/19/2005 5:11:31 PM
More...
|
Concurrent Pharmaceuticals Appoints Jeffrey Hatfield As Chief Executive Officer
10/19/2005 5:11:27 PM
More...
|
Concurrent Pharmaceuticals Announces $15 Million Private Financing, Collaboration With Intel In Machine Learning For Drug Discovery, And Rapid Progress On Renin Inhibitor Program
10/19/2005 5:09:39 PM
More...
|